Cabot Corporation (NYSE:CBT – Get Free Report) CEO Sean Keohane sold 134,895 shares of the business’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares of the company’s stock, valued at approximately $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Cabot Price Performance
NYSE CBT traded down $0.93 on Monday, hitting $82.72. 351,206 shares of the company’s stock were exchanged, compared to its average volume of 470,451. The stock has a 50-day moving average of $87.62 and a 200-day moving average of $81.24. The stock has a market cap of $4.27 billion, a price-to-earnings ratio of 23.30, a P/E/G ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $94.53. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. During the same quarter last year, the company posted $1.90 EPS. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Analysts expect that Cabot Corporation will post 6.35 earnings per share for the current year.
Cabot Announces Dividend
Institutional Trading of Cabot
Institutional investors and hedge funds have recently bought and sold shares of the stock. Corient Private Wealth LP grew its position in shares of Cabot by 2.0% in the 2nd quarter. Corient Private Wealth LP now owns 12,552 shares of the specialty chemicals company’s stock valued at $1,140,000 after buying an additional 241 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Cabot in the second quarter worth approximately $1,881,000. First Eagle Investment Management LLC boosted its holdings in Cabot by 52.5% in the second quarter. First Eagle Investment Management LLC now owns 208,450 shares of the specialty chemicals company’s stock valued at $18,931,000 after acquiring an additional 71,800 shares during the last quarter. California State Teachers Retirement System boosted its holdings in Cabot by 8,726.7% in the second quarter. California State Teachers Retirement System now owns 5,593,422 shares of the specialty chemicals company’s stock valued at $507,995,000 after acquiring an additional 5,530,053 shares during the last quarter. Finally, HB Wealth Management LLC acquired a new stake in Cabot during the 2nd quarter valued at approximately $239,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts have recently commented on CBT shares. Truist Financial set a $100.00 target price on shares of Cabot in a report on Wednesday, August 5th. Mizuho upped their price objective on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Finally, JPMorgan Chase & Co. increased their target price on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $89.00.
Read Our Latest Report on Cabot
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Recommended Stories
- Five stocks we like better than Cabot
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
